Alexander Kutikov, MD
Chief of the Division of Urology and Urologic Oncology
Fox Chase Cancer Center
Although the standard of care for muscle invasive bladder cancer (MIBC) is to remove the entire bladder, in some 30% of resections the organ is found to not harbor residual cancer, especially after neoadjuvant chemotherapy.
... to read the full story